Π-NET
Pulmonary Imaging Network
| Coordinatore | CENTRO DE INVESTIGACION BIOMEDICA EN RED
Organization address
address: CALLE MONFORTE DE LEMOS 5 contact info |
| Nazionalità Coordinatore | Spain [ES] |
| Totale costo | 3˙043˙599 € |
| EC contributo | 3˙043˙599 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2010-ITN |
| Funding Scheme | MC-ITN |
| Anno di inizio | 2010 |
| Periodo (anno-mese-giorno) | 2010-11-01 - 2014-10-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
CENTRO DE INVESTIGACION BIOMEDICA EN RED
Organization address
address: CALLE MONFORTE DE LEMOS 5 contact info |
ES (MADRID) | coordinator | 510˙648.00 |
| 2 |
THE UNIVERSITY OF SHEFFIELD
Organization address
address: FIRTH COURT WESTERN BANK contact info |
UK (SHEFFIELD) | participant | 581˙384.00 |
| 3 |
FUNDACION UNIVERSITARIA SAN PABLO-CEU
Organization address
address: ISAAC PERAL 58 contact info |
ES (MADRID) | participant | 480˙720.00 |
| 4 |
MRB Forschungszentrum fur Magnet-Resonanz-Bayern e.V.
Organization address
address: Am Hubland contact info |
DE (Wuerzburg) | participant | 472˙285.00 |
| 5 |
RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
Organization address
address: SEMINARSTRASSE 2 contact info |
DE (HEIDELBERG) | participant | 472˙285.00 |
| 6 |
ASTRAZENECA AB
Organization address
address: Vastra Maelarhamnen contact info |
SE (SODERTAELJE) | participant | 263˙205.00 |
| 7 |
UNIVERSITE DE BORDEAUX
Organization address
address: PLACE PEY BERLAND 35 contact info |
FR (BORDEAUX) | participant | 212˙086.00 |
| 8 |
UNIVERSITE LYON 1 CLAUDE BERNARD
Organization address
address: BOULEVARD DU 11 NOVEMBRE 1918 NUM43 contact info |
FR (VILLEURBANNE CEDEX) | participant | 50˙986.00 |
| 9 |
CIBER DEL AREA DE ENFERMEDADES RESPIRATORIAS
Organization address
address: "RECINTO HOSPITAL JOAN MARCH, CARRETERA DE SOLLER KM12" contact info |
ES ("BUNYOLA, MALLORCA") | participant | 0.00 |
| 10 |
UNIVERSITE VICTOR SEGALEN BORDEAUX II
Organization address
address: RUE LEO SAIGNAT 146 contact info |
FR (BORDEAUX CEDEX) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The lung is probably one of the most difficult organs to study by MRI because of its low proton density. Still, MRI is very interesting as not exposure of ionizing radiation to patients and its important role for translatability studies. Moreover, assessment of regional pulmonary perfusion and ventilation with clinical value as an indicator of lung function by MRI has been demonstrated using MRI based techniques both with hyperpolarized and fluorinated gases, oxygen and contrast agent free methods. The π-net ITN will undertake successful efforts (funded under the fifth and six framework program) and previous bilateral collaborative and complementary work of different European research teams to contribute to the field of lung functional MRI. π-net proposes very complementary and strongly interlinked research and training activities for these functional studies. The main research activity line aims at applying MRI based techniques for diagnosis (human and preclinical activities) and treatment (only preclinical) monitoring of lung diseases (COPD, lung cancer, cystic fibrosis, asthma), without excluding the possibilities that other imaging techniques (nuclear, CT and optical imaging) and molecular approaches (including molecular imaging and metabolomic analysis) may bring to the field. Π-net plans a training program to provide new ESR high level multidisciplinary scientific education and complementary skills for animal studies, MRI and other imaging techniques, and on translational aspects of research. The network is formed by 9 groups, located in 5 different countries (Spain, France, UK, Germany and Sweden). The centres hold researchers with previous experience in the network work and with researchers with high quality scientific production rate, and with experience in MRI physics, therapy, clinical, physiopathological and molecular aspects of respiratory diseases.'